Onyebuchi Ononogbu

Onyebuchi Ononogbu is a Research Assistant Professor at the University of Houston College of Pharmacy and a Hematology/Oncology Clinical Pharmacy Specialist at UT Physicians Adult Comprehensive Sickle Cell Center. His research focuses on Sickle Cell Disease, the microbiome, and Health Equity in hematology and oncology. He has published extensively on medication adherence in oncology and hematology patients, particularly those with low socioeconomic status and racial/ethnic minority backgrounds.

• Masters of Public Health in Epidemiology, University of Texas Health Sciences at Houston
• Doctor of Pharmacy, University of the Incarnate Word Feik School of Pharmacy
• Bachelor of Science in Allied Health and Diagnostic Sciences, University of Connecticut

His work spans clinical pharmacy, translational research, and public health, with recent publications analyzing adherence to oral endocrine therapy during the COVID-19 pandemic and the impact of the microbiome on chemotherapy toxicities. He has received awards such as the Diversity Equity and Inclusion Award (2024-2025) and Preceptor of the Year (2018). His grants and affiliations include Biomedical Informatics Certificate (2018) and Clinical Safety & Effectiveness Course (2020).

Dr. Ononogbu has presented at conferences including the San Antonio Breast Cancer Symposium and ACCP Annual Meeting, with research often addressing health disparities and equity in pharmaceutical care. He is a member of organizations like the Hematology/Oncology Pharmacy Association and American Society of Health-System Pharmacists.